Frequency of anxiety and depression in patients with melasma
DOI:
https://doi.org/10.66344/jpad.v30i1.1375Keywords:
Melasma, anxiety, depressionAbstract
Background Melasma is a common acquired hypermelanosis characterized by irregular brown patches occurring primarily on the forehead, cheeks and chin in a mask-like distribution. Melasma most commonly affects women of reproductive age. This chronic and recurrent condition causes a deleterious impact on various domains of patients’ quality of life.
Objective To determine the frequency of anxiety and depression in patients with melasma.
Methods A total of 195 cases of both gender with melasma and ages between 20-40 years were enrolled through non-probability consecutive sampling. Detailed history and examination were done. Hospital Anxiety and Depression Scale (HADS) was administered to all the patients. Scoring of anxiety and depression was done individually for each patient.
Results Out of 195 cases, 37% (n=73) were between 20-30 years of age and 63%(n=122) were of 31-40 years. Thirty-six patients (18.46%) were male and 159 (81%) were females. Frequency of anxiety in patients with melasma was recorded as 19.49% (n=38) and 10.77% (n=21) had depression.
Conclusion The frequency of anxiety and depression is high among patients with melasma. It is, therefore, recommended that patients who present with melasma may be evaluated for anxiety and depression severity and clinicians should have proper surveillance system to document the frequency of this problem.
References
1. Bandyopadhyay D. Topical treatment of melasma. Ind J Dermatol. 2009; 54(4): 303–9.
2. Passeron T. Melasma pathogenesis and influencing factors-an overview of the latest research. J Eur Acad Dermatol Venereol. 2013; 27: 5-6.
3. Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009; 23(11): 1254-62.
4. Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003; 149: 572-7.
5. Dominguez AR, Balkrishnan R, Ellzey AR, Pandya AG. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language. J Am Acad Dermatol. 2006; 55: 59-66.
6. Purim KS, Avelar MF. Photoprotection, Melasma and quality of life in pregnant women. Rev Bras Ginecol Obstet. 2012; 34(5): 228-34.
7. Ali R, Aman S, Nadeem M, Kazmi AH. Quality of life in patients of melasma. J Pak Assoc Dermatol. 2013; 23: 143-8.
8. Aslam R, Qadir A, Asad F. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. J Pak Assoc Dermatol. 2007; 17: 235-9.
9. Stern AF. The hospital anxiety and depression scale. Occupational Med. 2014; 64(5): 393-94.
10. Bystritsky A, Khalsa SS, Cameron ME, Schiffman J. Current diagnosis and treatment of anxiety disorders. Pharm & Therapeutics. 2013; 38(1): 30-57.
11. Sampogna F, Picardi A, Chren MM. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004; 66: 620–4.
12. Kanish B, Goyal SK, Thomas EA, Singla M, Kate P, Karma D. Depression and anxiety in melasma: prevalence and correlates in north India. Ind J Clin Exp Dermatol. 2017; 3(4): 167-71.
13. Bashir K, Dar NR, Rao SU. Depression in adult dermatology outpatients. J Coll Physicians Surg Pak. 2010; 20(12): 811-3.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Kalsoom Jawaid, Muhammad Shahid, Kehkshan Tahir, Nadia Ali, Asma Tariq, Abid Hussain
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
